Manchester Capital Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-898
| Closed | -$1K | – | 580 |
|
|
2019
Q4 | $1K | Hold |
898
| – | – | ﹤0.01% | 521 |
|
|
2019
Q3 | $1K | Hold |
898
| – | – | ﹤0.01% | 514 |
|
|
2019
Q2 | $0 | Hold |
898
| – | – | ﹤0.01% | 687 |
|
|
2019
Q1 | $0 | Hold |
898
| – | – | ﹤0.01% | 684 |
|
|
2018
Q4 | $0 | Hold |
898
| – | – | ﹤0.01% | 540 |
|
|
2018
Q3 | $0 | Hold |
898
| – | – | ﹤0.01% | 543 |
|
|
2018
Q2 | $0 | Hold |
898
| – | – | ﹤0.01% | 619 |
|
|
2018
Q1 | $0 | Hold |
898
| – | – | ﹤0.01% | 607 |
|
|
2017
Q4 | $0 | Hold |
898
| – | – | ﹤0.01% | 518 |
|
|
2017
Q3 | $0 | Hold |
898
| – | – | ﹤0.01% | 505 |
|
|
2017
Q2 | $0 | Hold |
898
| – | – | ﹤0.01% | 516 |
|
|
2017
Q1 | $0 | Hold |
898
| – | – | ﹤0.01% | 521 |
|
|
2016
Q4 | $0 | Hold |
898
| – | – | ﹤0.01% | 529 |
|
|
2016
Q3 | $0 | Hold |
898
| – | – | ﹤0.01% | 548 |
|
|
2016
Q2 | $0 | Hold |
898
| – | – | ﹤0.01% | 608 |
|
|
2016
Q1 | $0 | Hold |
898
| – | – | ﹤0.01% | 719 |
|
|
2015
Q4 | $0 | Hold |
898
| – | – | ﹤0.01% | 678 |
|
|
2015
Q3 | $0 | Hold |
898
| – | – | ﹤0.01% | 655 |
|
|
2015
Q2 | $1K | Hold |
898
| – | – | ﹤0.01% | 553 |
|
|
2015
Q1 | $0 | Hold |
898
| – | – | ﹤0.01% | 1120 |
|
|
2014
Q4 | $1K | Hold |
898
| – | – | ﹤0.01% | 1106 |
|
|
2014
Q3 | $0 | Hold |
898
| – | – | ﹤0.01% | 1135 |
|
|
2014
Q2 | $0 | Hold |
898
| – | – | ﹤0.01% | 1139 |
|
|
2014
Q1 | $0 | Hold |
898
| – | – | ﹤0.01% | 1027 |
|
|
2013
Q4 | $0 | Hold |
898
| – | – | ﹤0.01% | 1012 |
|
|
2013
Q3 | $2K | Hold |
898
| – | – | ﹤0.01% | 955 |
|
|
2013
Q2 | $2K | Buy |
+898
| New | +$1.58K | ﹤0.01% | 952 |
|
Manchester Capital Management's GCVRZ Position: Q1 2020 in Review
Manchester Capital Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 898 shares — an estimated $1K sold.
Manchester Capital Management first reported a position in GCVRZ in Q2 2013 and held it in 27 quarters. The position peaked at $2K in Q3 2013. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- Manchester Capital Management reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Manchester Capital Management sold 898 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $1K.
- Manchester Capital Management first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 27 quarters.
- Manchester Capital Management's Sanofi Contingent Value Rights position peaked at $2K in Q3 2013.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on Manchester Capital Management's 13F filing for Q1 2020, filed 14 May 2020.